Mednet Logo

Would you recommend axillary dissection for a patient with a clinically positive SCV or IMN node, who has a clinical CR to neoadjuvant chemo, but a positive SLNB?

Does it make sense to resect only the axillary nodes, but not the other involved nodal regions? Regional nodal radiation will be given.
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

My approach for this is to treat comprehensively with RT and boost any visible node/location where the prechemotherapy node existed and was not removed at surgery.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Penn Medicine
Answered on

This is a great question that I have seen many times clinically. The point is often made that Z-11 did not include such patients and therefore the logic to omit ALND with limited SLN positivity is inappropriately applied. However, the true question may be whether radiation can eradicate disease in t...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Allegheny Health Network, Pittsburgh
Answered on

With positive SLNB after neoadjuvant chemotherapy, I would favor dissection even if plan was to treat comprehensively afterwards. I understand that we don't dissect SCV or IMs routinely but standard practice has been to do ALND. I would boost undissected nodes in SCV/IM.

Join for free or sign in to see the full answer